Mitsubishi Tanabe steps further back from blood products
This article was originally published in Scrip
Executive Summary
Mitsubishi Tanabe Pharma (MTP) is moving its business further away from blood products and focusing on its core prescription drug operations through a decision to stop handling preparations from the Japan Blood Products Organization (JBPO).